跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VOLIBRIS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VOLIBRIS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
VOLIBRIS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Glaxosmithkline (Ireland) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 19, 2021
Approval ID
3e38876eb3106e65
Company
Glaxosmithkline (Ireland) Limited
Type
Standard
Approval Details
Approval Id
3e38876eb3106e65
Drug Cima Aemps Name
VOLIBRIS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
108451005
Holder Company Name
Glaxosmithkline (Ireland) Limited
Marketing Company Name
Glaxosmithkline S.A.
Holder Company Detail Path
/organization/glaxosmithkline-ireland-limited
Marketing Company Detail Path
/organization/glaxosmithkline-sa
Authorization Date
2021-10-19
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
2.5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Glaxosmithkline (Ireland) Limited
Company Detail Path
/organization/glaxosmithkline-ireland-limited
Company Information
Pharmaceutical Company Name
GLAXOSMITHKLINE (IRELAND) LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
12 RIVERWALK
Active Ingredients
AMBRISENTAN
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 19, 2021
Approval ID
3e38876eb3106e65
Type
Standard
Back to CIMA-AEMPS Approvals
